Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	77,515	76,639	93,403	77,057	66,029	50,990
Market Cap Growth	-1.78%	-17.95%	21.21%	16.70%	29.49%	24.22%
Enterprise Value	61,491	61,056	80,414	66,767	57,309	47,783
Last Close Price	755.51	708.40	873.45	717.51	628.04	480.45
PE Ratio	18.16	17.37	23.63	17.76	8.18	14.51
Forward PE	17.25	15.19	19.36	17.29	11.00	14.28
PS Ratio	5.61	5.40	7.12	6.33	4.11	6.00
PB Ratio	2.51	2.61	3.60	3.40	3.52	4.63
P/TBV Ratio	2.62	2.72	3.75	3.54	3.52	4.63
P/FCF Ratio	18.36	20.91	24.10	17.42	10.11	25.45
P/OCF Ratio	15.29	17.34	20.33	15.37	9.32	19.48
PEG Ratio	2.52	0.95	4.75	-	-	1.55
EV/Sales Ratio	4.32	4.30	6.13	5.49	3.57	5.62
EV/EBITDA Ratio	14.14	13.19	17.28	12.51	6.18	12.25
EV/EBIT Ratio	16.08	14.73	19.00	13.37	6.37	13.04
EV/FCF Ratio	14.57	16.66	20.75	15.09	8.78	23.85
Debt / Equity Ratio	0.09	0.10	0.11	0.12	0.14	0.25
Debt / EBITDA Ratio	0.62	0.63	0.60	0.52	0.29	0.69
Debt / FCF Ratio	0.64	0.80	0.72	0.63	0.41	1.35
Asset Turnover	0.37	0.40	0.42	0.45	0.76	0.53
Inventory Turnover	2.46	2.51	2.51	2.37	2.74	2.26
Quick Ratio	3.19	3.86	4.82	4.16	2.98	2.86
Current Ratio	4.06	4.73	5.69	5.06	3.56	3.63
Return on Equity (ROE)	15.19%	15.95%	16.26%	20.94%	54.21%	31.77%
Return on Assets (ROA)	6.16%	7.31%	8.49%	11.42%	26.39%	14.33%
Return on Invested Capital (ROIC)	13.50%	18.58%	22.38%	26.65%	60.13%	36.09%
Return on Capital Employed (ROCE)	10.70%	12.30%	14.30%	19.20%	41.80%	25.30%
Earnings Yield	5.91%	5.76%	4.23%	5.63%	12.23%	6.89%
FCF Yield	5.45%	4.78%	4.15%	5.74%	9.89%	3.93%
Buyback Yield / Dilution	4.39%	-1.23%	-0.18%	-1.16%	2.52%	-0.44%

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q